K190956

Substantially Equivalent

SCS 17-01

Applicant: Anika Therapeutics, Inc.
Product code: MQV
Advisory panel: Orthopedic
Date received: 2019-04-11
Decision date: 2020-01-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beford, MA, US

Adverse events under product code MQV

product code MQV

Death: 6
Injury: 435
Total: 441

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.